AIP
APLT

Ameritas Investment Partners’s Applied Therapeutics APLT Stock Holding History

Ameritas Investment Partners’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,419
Closed -$4.61K – 3208
2025
Q1 		$4.61K Hold
9,419
– – ﹤0.01% 2991
2024
Q4 		$8.06K Hold
9,419
– – ﹤0.01% 2954
2024
Q3 		$80.1K Hold
9,419
– – ﹤0.01% 1925
2024
Q2 		$44K Buy
+9,419
New +$44.6K ﹤0.01% 2216
2022
Q2 		– Sell
-1,179
Closed -$2K – 3068
2022
Q1 		$2K Hold
1,179
– – ﹤0.01% 3042
2021
Q4 		$11K Hold
1,179
– – ﹤0.01% 2857
2021
Q3 		$20K Hold
1,179
– – ﹤0.01% 2690
2021
Q2 		$25K Hold
1,179
– – ﹤0.01% 2612
2021
Q1 		$22K Hold
1,179
– – ﹤0.01% 2520
2020
Q4 		$26K Hold
1,179
– – ﹤0.01% 2333
2020
Q3 		$24K Hold
1,179
– – ﹤0.01% 2272
2020
Q2 		$43K Buy
1,179
+630
+115% +$26.4K ﹤0.01% 1917
2020
Q1 		$18K Hold
549
– – ﹤0.01% 2226
2019
Q4 		$15K Buy
549
+379
+223% +$6.49K ﹤0.01% 2542
2019
Q3 		$2K Buy
+170
New +$1.6K ﹤0.01% 3012

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Ameritas Investment Partners's APLT Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 9,419 shares — an estimated $4.61K sold.

Ameritas Investment Partners first reported a position in APLT in Q3 2019 and held it in 15 quarters. The position peaked at $80.1K in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 9,419 Applied Therapeutics shares in Q2 2025, an estimated $4.61K.
  • Ameritas Investment Partners first reported a position in Applied Therapeutics in Q3 2019 and held it in 15 quarters.
  • Ameritas Investment Partners's Applied Therapeutics position peaked at $80.1K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.